噻托溴铵雾剂联合N-乙酰半胱氨酸泡腾片对慢性阻塞性肺疾病患者的临床疗效

Clinical effect of tiotropium bromide powder for inhalation combined with N-acetylcysteine effervescent tablets for patients with chronic obstructive pulmonary disease

  • 摘要: 目的 探讨噻托溴铵雾剂联合N-乙酰半胱氨酸(NAC)泡腾片对慢性阻塞性肺疾病患者临床疗效和肺功能的影响。 方法 将本院86例慢性阻塞性肺疾病患者分为对照组和观察组,每组43例。2组均给予纠正水电解质紊乱、化痰止咳、吸氧等常规治疗,对照组在常规治疗基础上采用噻托溴铵雾剂治疗,观察组在常规治疗上给予噻托溴铵雾剂联合NAC泡腾片治疗,疗程均为4周。比较2组临床疗效、肺功能、动脉血气相关指标及炎性因子水平。 结果 观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。2组治疗后第1秒用力呼气量(FEV1), 第1秒用力呼气量与用力肺活量比值(FEV1/FVC)、最大呼气量(PEF)及肺活量(VC)均升高,且观察组上述指标高于对照组,差异有统计学意义(P<0.05)。2组治疗后动脉血氧分压[pa(O2)]、血氧饱和度(SaO2)升高,动脉血二氧化碳分压[pa(CO2)]下降,其中观察组治疗后pa(O2)、SaO2高于对照组, pa(CO2)低于对照组,差异有统计学意义(P<0.05)。2组治疗后肿瘤坏死因子(TNF-α)、超敏C反应蛋白(hs-CRP)和白细胞介素-6(IL-6)水平均降低,且观察组治疗后上述指标均低于对照组,差异有统计学意义(P<0.05)。 结论 噻托溴铵雾剂联合NAC泡腾片治疗慢性阻塞性肺疾病临床疗效较好,可改善患者肺功能,减轻机体炎症反应。

     

    Abstract: Objective To explore the effect of tiotropium bromide powder for inhalation combined with N-acetylcysteine(NAC)effervescent tablets on the clinical efficacy and lung function of patients with chronic obstructive pulmonary disease. Methods A total of 86 chronic obstructive pulmonary disease patients in our hospital were divided into control group and observation group, with 43 cases in each group, patients of two groups were given water electrolyte disorder correcting, resolving phlegm and relieving cough oxygen and other conventional treatments, the control group was given tiotropium bromide powder for inhalation on the basis of conventional treatment, the observation group was given tiotropium bromide powder for inhalation and NAC effervescent tablets based on the conventional treatment. Treatment was lasted for 4 weeks. Clinical efficacy, lung function, arterial blood gas related indexes and inflammatory factors were compared between the two groups. Results The total effective rate of the observation group was significantly higher than that in the control group(P<0.05). After treatment, forced expiratory volume in one second(FEV1), ratio of FEV1 to forced vital capacity(FVC)(FEV1/FVC), peak expiratory flow(PEF)and forced vital capacity(VC)were all increased in the two groups, and the above indexes in the observation group were significantly higher than those in the control group(P<0.05). After treatment, arterial partial pressure of oxygen[pa(O2)] and oxygen saturation(SaO2)in the two groups were increased, while partial pressure of carbon dioxide in - artery[pa(CO2)] was decreased, and the observation group had higher levels of pa(O2)and SaO2, and lower pa(CO2)level than the control group(P<0.05). Tumor necrosis factor-α(TNF-α), high sensitive C-reactive protein(hs-CRP)and interleukin-6(IL-6)levels were all decreased after treatment in both groups, and the above indexes in the observation group were all significantly lower than those in the control group(P<0.05). Conclusion Tiotropium bromide powder for inhalation combined with NAC effervescent tablets has a good clinical effect in the treatment of chronic obstructive pulmonary disease, which can improve patients' lung function and relieve inflammatory response.

     

/

返回文章
返回